- Report
- March 2025
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 377 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- July 2024
- 154 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- November 2021
- 111 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$3,944USD£3,043GBP
The Cardiac POC Testing Devices market is a subset of the Point-of-Care Diagnostics market, which focuses on providing rapid, accurate, and cost-effective diagnostic testing at the point of care. Cardiac POC Testing Devices are used to detect cardiac biomarkers, such as troponin, in order to diagnose and monitor cardiac conditions. These devices are typically portable, easy to use, and provide results in a short amount of time. This allows healthcare providers to quickly diagnose and treat cardiac conditions, reducing the risk of complications and improving patient outcomes.
Some companies in the Cardiac POC Testing Devices market include Abbott, Roche, Siemens, and Alere. Show Less Read more